FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10161711000001105: Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
32332101000001110 Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
32332201000001115 Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Gastroenteral route true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route gel.gastroenteral ontology form and route true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Is a Co-careldopa true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Is a Product containing carbidopa and levodopa false Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Plays role Antiparkinson therapeutic role true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Has basis of strength substance Carbidopa false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette 7 bag Is pack of False Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Inferred relationship Existential restriction modifier
Duodopa intestinal gel cassette 100ml (Solvay Healthcare Ltd) Is a True Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette 1 bag Is pack of False Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette 1 bag Has VMP True Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Inferred relationship Existential restriction modifier
Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette 7 bag Has VMP True Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start